Pericardial Heart Valves
Magna Ease Aortic Valve
Magna Mitral Valve
Magna Aortic Valve
Theon Mitral System
Theon Aortic
PERIMOUNT Mitral
PERIMOUNT Aortic
Related Products

Why Compromise with Lifelong Anticoagulation

For Patients

Request Information
Technical Information

Heart Valve News
Report from NPR
2006 ACC / AHA Guidelines

Reimbursement
Carpentier-Edwards PERIMOUNT Theon
Mitral Replacement System
The integrated PERIMOUNT Theon mitral replacement system is designed to answer the specific challenges of mitral heart valve replacement, facilitate the implantation process, and maximize clinical outcomes for both surgeon and patient.7

Built to last
  • The actual freedom from explant due to SVD is 89% at 16 years1 in patients 60 and over.
  • New Carpentier-Edwards ThermaFix advanced tissue process extracts both major calcium binding sites3 and is not a reversible binding like other tissue treatments.4  
Made for mitral
  • Designed for the mitral heart valve position,5 not just an aortic pig valve turned upside down.6
  • Bioengineered to avoid the variability inherent in natural pig valves.5
Designed for surgeons
  • New specific mitral handle.
  • New performance-based sizing.
  • Improved Edwards Tricentrix holder system.
  • Flexible waffled silicone sewing band.
Better for patients
  • No need for lifelong anticoagulation,* widening lifestyle choices and therapeutic options to treat comorbidities.8
  • Slow mode of failure allows for clinical detection—and in many cases an elective low-risk reoperation.9,10
  • Superior hemodynamics benefits all patients.11  
No clinical data are available which evaluates the long-term impact of Edwards Lifesciences tissue treatments in patients.
*For patients who do not require warfarin for other risk factors and after 3-month usual postoperative period.2

References
1. Carpentier-Edwards PERIMOUNT mitral pericardial bioprosthesis 16-year Results. Data on file at Edwards Lifesciences, 2003.
2. Bonow et al., AHA/ACC Guidelines. J Am Coll Cardiol 98;32:1486-588.
3. Data on file at Edwards Lifesciences RD 784, RD 795, RD 597, RD 127, and RD 128.
4. Chen W, et al. Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde-protreated porcine bioprosthetic heart valves. Circulation 1994;90(1):323-9.
5. Design history files – Data on file at Edwards Lifesciences.
6. Swine as Models in Biomedical Research. Swindle MM, editor. Iowa State University Press, Ames, Iowa 1992.
7. Carpentier-Edwards PERIMOUNT Theon mitral replacement system – Product insert.
8. Coumadin Product Insert - 6672-01/Rev June 2002.
9. Jamieson WR, et al. Reoperation for bioprosthetic mitral structural failure: risk assessment. Circulation 2003;108[suppl II]:II-98-102.
10. Jones TM, et al. Repeat heart valve surgery: Risk factors for operative mortality. J Thorac Cardiovasc Surg 2001;122:913-8.
11. Gudbjartsson T, Aranki S, Cohn LH. Mechanical/Bioprosthetic Mitral Valve Replacement.
In: Cohn LH, Edmunds LH Jr, eds. Cardiac Surgery in the Adult. New York: McGraw-Hill, 2003:951986. Chapter 38
Rx only.  See instructions for use for full prescribing information.
Brochures
Models
Accessories
Implantation Video
Tissue or Mechanical?
DM Cosgrove vs TE David
Clinical Communique
ThermaFix Process
Thought Leaders
Presentations, Educational
Exposure Technique
Prolapse & Aneurysm
Alain Carpentier MD, PHD
Echo Case Studies
Atrial Fibrillation

Important Risk Information
Contact Us | Legal Terms | Privacy Policy | © 2010 Edwards Lifesciences LLC. All rights reserved.